Global Clinical Trial Landscape – Focus On Asia Pacific

whitePaper | July 26, 2022

Healthcare leaders have long recognized the importance of real-time decision making. Take, for instance, sepsis one of the leading causes of U.S. hospital deaths that costs the industry an estimated $62B a year,1 not to mention the preventable morbidity

whitePaper | November 12, 2022

The past two years have seen accelerated adoption and utilization of telehealth services by a majority of healthcare organizations, driven in large part by the COVID-19 pandemic.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

whitePaper | November 19, 2022

Now, more than ever, sponsors and CROs need to prioritize including patient engagement in their study builds from the ground-up. This involves defining processes to remove barriers for access.

whitePaper | November 17, 2021

Nearly every healthcare provider has been hit by ransomware, and the onslaught continues unabated, now affecting patient care with once-unimaginable patient-care consequences. This whitepaper, crafted with healthcare CISOs, details seven critical areas to defend or recover from ransomware attacks. Its pragmatic approach helps ensure business operations and patient care while giving risk teams the tools to manage third parties and other systems involved in business and clinical value chains.